A Phase 4 interventional study of NSAID and Opioid in Surgery and Pain, Post Operative, sponsored by University of Michigan. Recruiting at 9 sites in United States. Open to participants aged 12 Years to 20 Years. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by University of Michigan · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative — 22 open to participants now, 25 under way, 3 of them phase 3. A drug class: Anti-Inflammatory Agents, Non-Steroidal · Pain, Postoperative.
Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, this one is the 5th largest by planned enrollment, is one of 10 that started in 2025, is one of 84 in phase 4, reaches primary completion later than 9 of the 24 other live ones, and was the 210th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →22 of the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative are open now, in 8 countries. Recruiting first, the newest first:
Moumtzidou Maria Aikaterini · Sites in Greece
Ages 18+ · Women only
Northwestern University · Sites in United States
Ages 18–80
University of Puerto Rico · Sites in Puerto Rico
Ages 21–65
Jessica D. Kresowik · Sites in United States
Ages 18–37 · Women only
University of Oklahoma · Sites in United States
Ages 18–110
By country, each count listing its studies:
A class of medicines: which ones, and the studies of each, are on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 12 Years to 20 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
229 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 40 · Phase 3 56 · Phase 4 84
First in 2000; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 900 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 229 interventional studies. Of the 168 that completed or were terminated, 70 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
55 of 229 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,509 studies on the registry; 194 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 134 (79%) have results posted.
University of Michigan has 6 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
12 of the studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03823534Phase 3St. Louis UniversityPost-Op Pain Control for Prophylactic Intramedullary Nailing. | 2027-03-31 |
| NCT07047040Phase 3Assiut UniversityAnalgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin | 2027-10-30 |
| NCT07571252University of Puerto RicoImpact of Preemptive Analgesia on Postoperative Pain in Orthognathic Surgery | 2026-12 |
| NCT05919745Marquette UniversityPreemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft | 2026-12 |
| NCT06379425Northwell HealthImpact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries | 2027-01-01 |
Add all 12 to your calendar (.ics) → With an account.
Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This trial is being completed to compare two commonly used options to treat pain after discharge from surgery. Participants that undergo tonsil removal, gallbladder removal, and knee scope will be eligible to enroll. Eligible participants will be randomized to prescription of 1 of 2 groups of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) plus acetaminophen or low dose opioids with the NSAIDs plus acetaminophen. The key question the study seeks to answer is which option will have the best outcomes and with the fewest side effects?
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: NSAID · Drug: Acetaminophen
Drug: Opioid · Drug: Acetaminophen · Drug: Ibuprofen
Once randomized to this group the surgical team will elect to prescribe 1 of the following treatment options for post-discharge pain: * Ibuprofen 10 milligrams(mg)/kilogram (kg) (maximum 600mg) by mouth every 6 hours around the clock for 2 days, then as needed for pain thereafter (40 doses) * Celecoxib 6mg/kg (maximum 400mg) by mouth once then 3 mg/kg (maximum 200mg) every 12 hours around the clock for 2 days, then as needed for pain thereafter (40 doses)
Also known as: Ibuprofen, Celecoxib
Once randomized to this group the surgical team will elect to prescribe for 1 of the following treatment options to be given post procedure for post-discharge pain: * Oxycodone 0.1 mg/kg (maximum 5 mg) by mouth every 4 to 6 hours as needed for pain, number 10 doses. * Hydromorphone 0.04 mg/kg (maximum mg) by mouth 4 to 6 hours as needed, number 10 doses
Also known as: Oxycodone, Hydromorphone
Participants will receive 15mg/kg up to 1000mg by mouth every 6 hours around the clock for the first 2 days after discharge from surgery then as needed thereafter (40 doses)
Ibuprofen 10mg/kg (maximum 600 mg) by mouth every 6 hours around the clock for 2 days after discharge from surgery then as needed thereafter (40 doses)
Effectiveness outcome - Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 14 days post-surgery
This is a one question survey in which the worst pain intensity recorded (0-10 being the worst) will be used.
Time frame: 14 days post-surgery, and up to 12 months after surgery
Safety outcome - number and severity of any adverse medication-related symptoms over 14 days post-surgery
Symptom Checklist will proactively screen patients for reports of adverse events from analgesic medications over the first 14 days post-surgery.
Time frame: 14 days post-surgery, and 1 month after surgery
Patient Reported Outcomes Measurement Information System (PROMIS) Pediatric Sleep Disturbance v1.0 short form 4a
This is a 4-question survey in which participants will rate statements pertaining to quality of sleep. Participants will also rate sleep quality as very poor (5), poor (4), fair (3), good (2), or very good (1).
Time frame: Baseline and 1 month after surgery
Patient Global Impression of Change (PGIC)
The perception of improvement or worsening after treatment will be assessed by the patient global impression of change PGIC (range 0-7).
Time frame: Day 7 up to 12 months after surgery
PROMIS Pediatric Pain Interference scale (Short form-8a)
This is an 8-question survey in which participants will rate statements pertaining to how pain interferes with activities and function.
Time frame: Baseline up to 12 months after surgery
Pain Catastrophizing Scale (PCS)
This is a 6-question survey in which participants will rate statements pertaining to their experience of pain.
Time frame: Baseline up to 12 months after surgery
Pediatric Quality of Life Inventory Short Form 15
There are 15 questions with four scales for function related to physical, emotional, social, and school dimensions for adolescents. Participants answer questions from never (0) to almost always (4).
Time frame: Baseline up to 12 months after surgery
Quality of Recovery (QoR) 15
There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.
Time frame: Day 3, 1 week, and 2 weeks after surgery
Patient Health Questionnaire (PHQ-2)
There are 2 questions that are completed to screen for depression. Participants answer from not at all (0) to Nearly every day (3). The scores range from 0-6 with a higher score indicating higher levels of depression.
Time frame: Baseline up to 12 months after surgery
Generalized Anxiety Disorder (GAD-2)
There are 2 questions that are completed to screen for anxiety. Participants answer from not at all (0) to Nearly every day (3). The scores range from 0-6 with a higher score indicating higher levels of anxiety.
Time frame: Baseline up to 12 months after surgery
Brief Screening Instrument for Adolescent Tobacco, Alcohol, and Drug Use
This is a 6-question survey about the participants' use of tobacco, alcohol and drugs.
Time frame: Baseline up to 12 months after surgery
National Survey on Drug Use and Health Questions on Opioid Misuse
This is a one question survey that assesses opioid misuse defined as use that is more than prescribed, for non pain-related reasons, or in a way not prescribed by a doctor.
Time frame: Baseline up to 12 months after surgery
New prolonged opioid use
One question that will assess opioid prescription fills to identify new prolonged opioid use after surgery
Time frame: Up to 12 months after surgery
Acute pain based on The Michigan Body Map
Participants will document/mark on this image map to identify areas in which acute pain was felt.
Time frame: Up to 12 months after surgery
Chronic pain based on Body Map
Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.
Time frame: Up to 12 months after surgery
Chronic pain based on Brief Pain Inventory (BPI) pain intensity score up to 12 months after surgery
One question survey in which the participants rate pain intensity recorded (0-10), ten being the worst.
Time frame: to 12 months after surgery
Healthcare Utilization related to pain
Participants will answer questions about their healthcare utilization related to pain for the following three events: (1) postoperative clinical interactions related to pain in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations. The study team will also review health record for the same events.
Time frame: Up to 12 months after surgery
Analgesic medication use
Participants will answer questions about their analgesic medication use for acetaminophen, NSAIDs, opioids, and other medications, including prescription fills, over-the-counter use, and consumption. The study team will also review health record for prescription fills.
Time frame: Up to 12 months after surgery
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Plan to share: Yes — Individual participant data that underlie the results of the trial that is not subject to restrictions based on data sharing agreements (e.g., prescription drug monitoring program data), after deidentification
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Anticipated summer 2029 with no end date
Access criteria: Investigators can access the IPD and supporting information for analyses related to aims in the proposal. The proposed used of the data needs to be approved by a review committee and the sponsor. Proposals may be submitted up to 36 months after data availability, after which data will be available in a data warehouse but without investigator support.
Started Jan 2025 (actual). Primary completion is estimated for Oct 2026, 21 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 21 months is above that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Anti-Inflammatory Agents, Non-Steroidal · Opioids · Ibuprofen